Abstract
Environmental conditions, resource limitations, and unavailability of certain antifungal (AF) agents are important challenges in management of invasive fungal infections in Asian countries. Lack of awareness and inadequate expertise also produces various pitfalls in management. There is an unmet need of addressing all these concerns, as also of generating and locally validating novel low cost management strategies. Intensive educational activities and AF stewardship need to be emphasized to prevent Asia from becoming an AF resistance hotspot in future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaur H, Chakrabarti A. Strategies to reduce mortality in adult and neonatal candidemia in developing countries. J Fungi. 2017;3:41.
Bongomin F, Gago S, Oladele R, Denning D, et al. Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi. 2017;3:57.
Chakrabarti A, Sood P, Rudramurthy SM, et al. Incidence, characteristics and outcome of ICU acquired candidemia in India. Intensive Care Med. 2015;41:285.
Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.
Chakrabarti A. Opportunistic fungal infections in Asia. In: Fungal infections in Asia. The Eastern Frontier of Mycology. 2013; Elsevier. p. 11–21.
Bassetti M, Bouza E. Invasive mould infections in the ICU setting: complexities and solutions. J Antimicrob Chemother. 2017;72(1):i39–47.
Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–e60. https://doi.org/10.1093/cid/ciw326.
Chakrabarti A, Chatterjee SS, Shivaprakash MR. Overview of opportunistic fungal infections in India. Nippon Ishinkin Gakkai Zasshi. 2008;49:165–72.
Yuchong C, Fubin C, Jianghan C, et al. Cryptococcosis in China (1985-2010): review of cases from Chinese database. Mycopathologica. 2012;173:329–35.
Bhansali A, Bhadada S, Sharma A, et al. Presentation and outcome rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004;80:670–4.
Marak RS, Misra R, Ansari MS, et al. Successful medical management of renal zygomycosis: a summary of two cases and a review of the Indian literature. Med Mycol. 2010;48:1088–95.
Yu J, Li RY. Primary renal zygomycosis due to Rhizopus oryzae. Med Mycol. 2006;44:461–6.
Soman R, Gupta N, Sohanlal T, Shetty A, Hegde A, Sankhe M, Rodrigues C. Insect bite causing mucormycosis: report of two cases. JIMSA. 2010;23(1):57.
Chamilos G, Lewis R, Kontoyiannis D. Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. CID. 2018;47(4):503–9.
Lamaris GA, Ben-Ami R, Lewis RE, et al. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis. 2009;199:1399–406.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Soman, R., Sunavala, A. (2020). Challenges, Pitfalls, and Possible Solution for Asian Countries. In: Chakrabarti, A. (eds) Clinical Practice of Medical Mycology in Asia. Springer, Singapore. https://doi.org/10.1007/978-981-13-9459-1_21
Download citation
DOI: https://doi.org/10.1007/978-981-13-9459-1_21
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9458-4
Online ISBN: 978-981-13-9459-1
eBook Packages: MedicineMedicine (R0)